Mise à jour
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Maladies infectieuses 2025BASE DE CONNAISSANCES MÉDICALES
Recommandations cliniques
Retrouvez les recommandations officielles, consensus et mises à jour publiés par les sociétés savantes et autorités de santé.
Sources officielles et fiablesSociétés savantes et autorités de santé
Informations mises à jourVeille scientifique continue
Accès gratuit pour les professionnelsAu service de la communauté médicale
APPLICATION ASEM
Des recommandations cliniques, où que vous soyez
Explorez les recommandations médicales officielles et les guides de pratique clinique dans l’application ASEM.
Télécharger l’application ASEMPublications et mises à jour importantes
Voir les publications récentes
Mise à jour
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Cardiologie 2025
Publication officielle
WHO guidelines on the integrated management of obesity in adolescents
World Health Organization
Pédiatrie 2026Toutes les recommandations (524 résultats)
Filtres
Archived 41: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada [2022-06-29]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 41: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster prog...
Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikeva...
Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age [2022-07-14]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5...
Archived 43: Summary of NACI statement of August 19, 2022: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 43: Summary of NACI statement of August 19, 2022: Recommendations on the use of a first boost...
Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age [2022-08-19]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19...
Archived 44: Summary of NACI statement: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 44: Summary of NACI statement: Updated guidance on COVID-19 vaccines for individuals who are...
Archived 44: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding [2022-09-09]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 44: Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding [...
Archived 45: Summary of NACI statement of October 7, 2022: Updated guidance on COVID-19 vaccine booster doses in Canada
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 45: Summary of NACI statement of October 7, 2022: Updated guidance on COVID-19 vaccine booste...
Archived 45: Updated guidance on COVID-19 vaccine booster doses in Canada [2022-10-07]
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 45: Updated guidance on COVID-19 vaccine booster doses in Canada [2022-10-07] ». Extrait offi...
Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age
National Advisory Committee on Immunization
Document officiel de National Advisory Committee on Immunization (2022) sur « Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNT...